NEW DELHI (Reuters) – Johnson & Johnson is interested in manufacturing its COVID-19 vaccine in India, a government official told a news conference on Tuesday.
India also currently has no concern over the efficacy of the AstraZeneca vaccine that is being used in the country’s massive inoculation campaign, Vinod Kumar Paul said.
(Reporting by Krishna N. Das and Sai Sachin Ravikumar; Editing by Gareth Jones)
